• Explore /
  • Poster
  • / Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort.

Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort.

Abstract Poster

Authors

null

Lingying Wu

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China

Lingying Wu , Jianqing Zhu , Rutie Yin , Xiaohua Wu , Ge Lou , Jing Wang , Yunong Gao , Beihua Kong , Xin Lu , Qi Zhou , Yueling Wang , Youguo Chen , Weiguo Lu , Wei Li , Ying Cheng , Jihong Liu , Xin Ma , Jing Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT01844986

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5554)

DOI

10.1200/JCO.2019.37.15_suppl.5554

Abstract #

5554

Poster Bd #

377

Abstract Disclosures

Similar Posters

First Author: Michael Friedlander

First Author: Domenica Lorusso

First Author: Sana Intidhar Labidi-Galy

First Author: Michele Bartoletti